SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following positive Phase 2 S-OLARIS trial results for sonelokimab in axial spondyloarthritis, which showcased clinically meaningful benefits and objective evidence of disease modification, positioning it as a potential best-in-class therapy. The strong clinical data and a robust cash position are driving community discussions about its significant undervaluation, potential for a short squeeze, and anticipation of further positive updates at its upcoming Investor Day.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPDR S&P 500 ETF Trust is trending due to renewed global trade uncertainty, as President Trump's re-imposed 15% worldwide tariffs draw international pushback from the EU and India. The market community is deeply split between predictions of a significant market downturn and expectations for underlying resilience to absorb the news, with upcoming Nvidia earnings also in focus.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver Corporation is trending due to its strong financial performance, marked by record revenue and treasury position, which has fueled community excitement and multi-year highs. Investors are particularly focused on the company's unique position as a pure-play silver miner with its own mint, allowing it to capture premiums amid a broader rally in precious metals and anticipated supply dynamics.

Karman Holdings, Inc. engages in the design, testing, manufacturing, and sale of dependable missile systems. It offers Payload Protection & Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company was founded on August 20, 2020 and is headquartered in Huntington Beach, CA.

Karman Holdings Inc.

Karman Holdings Ord Shs

Karman Holdings is generating buzz amid its strong financial performance, which includes exceeding revenue expectations, securing major defense contracts, and strategic acquisitions in the space and defense sectors. While the stock has seen recent volatility, the community views current dips as a significant buying opportunity, highlighting its critical role in advanced missile and hypersonic technologies.

Lizard

LIZARD CRYPTO is trending due to active community efforts to boost its viral status, driven by a meme contest and social media buzz, with many anticipating significant growth and potential major exchange listings for the meme coin, while others remain skeptical.

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix Network is seeing heightened community excitement driven by its upcoming $1 million trading competition and significant protocol developments, including its full return to Ethereum Mainnet for perps trading. Adding to the bullish sentiment, the community is actively discussing the recent end of SNX token inflation and the impending launch of token buybacks, signaling a major shift in its tokenomics.

BtcUSD is a completely decentralized stablecoin issued and managed by BTCFi, a platform where users can deposit Bitcoin of various formats to use as collaterals. BtcUSD offers Bitcoin holders the opportunity to generate additional yields with their Bitcoin positions through DeFi usage.

Bitcoin USD (BTCFi)

Bitcoin is trending amidst significant volatility, as technical support levels are tested following recent ETF outflows and profit-taking, fueling a divided community discussion between deeper corrections and long-term accumulation opportunities. Ongoing developments in institutional adoption, like the South Dakota House Bill 1155, continue to shape the narrative around its maturing role as a reserve asset.

JFrog Ltd. engages in the provision of an end-to-end, hybrid, universal development operations platform that powers and controls the software supply chain, which enables organizations to continuously and securely deliver software updates across any system. It operates through the following geographical segments: United States, Israel, India, and Rest of World. The firm is also involved in creating software delivered without friction from developer to device. The company was founded by Frederic Simon, Shlomi Ben Haim, and Yoav Landman in 2008 and is headquartered in Sunnyvale, CA.

JFrog Ltd

JFrog ($FROG) is trending following a significant sell-off after Anthropic's Claude Code Security preview, sparking a divided community discussion between those fearing AI disruption and others, including analysts, who view the extreme market reaction as an excessive overcorrection and a buying opportunity for the company's core DevSecOps value.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is experiencing a surge in attention following its strong Q3 revenue growth and recent operational triumphs, including securing Switzerland's first fully driverless robotaxi permit and launching commercial services with Uber in Abu Dhabi; however, the community is actively debating its valuation and seeking clearer management guidance amidst news of NVIDIA selling its stake.

What is Tron? Tron's mission is to build a truly decentralized internet and aims to be the largest blockchain-based operating system in the world, known as the TRON protocol. The TRON protocol will offer high scalability, high availability, and high throughput computing to serve decentralized applications via smart contracts. Ethereum EVM-based smart contracts will be compatible and deployable on the TRON network as such Solidity developers do not have to rewrite their applications.  Why Tron? Since TRON protocol does not rely on proof of work or mining, instead governed by nodes located around the world, it is decentralized while providing high throughput for transactions on the blockchain. This is suitable for dapps that require high speed transactions especially games. There are a number of tokens already issued on the TRON network and the decentralized exchanges TRX.market has launched.  On July 24th 2018, TRON acquired BitTorrent, one of the largest P2P file sharing protocol. As a result of the acquisition, BitTorrent Token (BTT) was launched as the cryptocurrency to power the economics on the BitTorrent network. The Token will be used to inceltivize file sharing and storage within the network.

Tron

Tron (TRX) is garnering attention for its robust performance during recent market dips and its critical role in global stablecoin transfers, evidenced by new integrations and widespread adoption for low-cost transactions. However, community sentiment is mixed, with discussions also focusing on Tether's recent freezes of wallets on the Tron network and renewed regulatory questions surrounding its founder.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025

Key PointsRedmile Group bought 16,317 shares of Krystal Biotech; the estimated trade size was $3.43 million based on average closing prices in the fourth quarter...

Krystal Biotech, Inc. $KRYS Shares Sold by Aberdeen Group plc

Aberdeen Group plc lessened its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 45.3% in the third quarter, according to the company in its most recent Form 13F filing with the...

Krystal Biotech (NASDAQ:KRYS) Trading Down 6.9% - Here's Why

Krystal Biotech (NASDAQ:KRYS) Stock Price Down 6.9% - Time to Sell...

HC Wainwright Forecasts Krystal Biotech Q1 Earnings

Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Krystal Biotech in a research note issued to...

Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark

KRYS beats Q4 estimates as Vyjuvek sales jump 17%. It secures 660+ U.S. reimbursements and advances the gene therapy pipeline into 2026.

Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $323.00

Chardan Capital upped their price objective on shares of Krystal Biotech from $220.00 to $323.00 and gave the stock a "buy" rating in a research report on Wednesday...

Expert Outlook: Krystal Biotech Through The Eyes Of 9 Analysts

Stock Market News for Feb 18, 2026

U.S. stock markets closed higher on Tuesday. Stock prices were muted yesterday as major indexes were mostly sidetracked. 

Readystate Asset Management LP Sells 77,631 Shares of Krystal Biotech, Inc. $KRYS

Readystate Asset Management LP trimmed its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 52.5% in the 3rd quarter, according to the company in its most recent disclosure with the...

Krystal Biotech (NASDAQ:KRYS) Hits New 1-Year High After Earnings Beat

Krystal Biotech (NASDAQ:KRYS) Sets New 1-Year High on Earnings Beat...

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Current Price	$261.80
Prev Close	$262.67
Open	$261.51
Dividend Yield	0.00%
50-Day Moving Average	$263.62
Beta	0.97
Avg. Volume	314,786.20
PE Ratio	38.25

52-Week High	$298.30
52-Week Low	$122.80
Market Capitalization	$7.65B
EPS (Annual)	$6.84
Price to Book	6.27
Revenue Per Employee	$1.32M

KRYS
Krystal Biotech Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KRYS News

KRYSKrystal Biotech Inc